The compound has been investigated during the patent literature for its anxiolytic Qualities and reduced sedative, hypnotic, and ataxic side-effects, but it does not appear to be accredited for health care use. Łukasik-Głebocka et al Pyrazolam is really a triazolo-BZD with apparently little information and facts, structurally comparable to https://donovanuhqyf.blogspothub.com/35248437/top-guidelines-of-flubromazolam-vs-alprazolam